SEMAGLUTIDE INJECTIONS FOR WEIGHT LOSS SUPPORT
According to the U.S. Food and Drug Administration (FDA), approximately 70% of American adults are overweight or obese.
This can lead to consequences such as heart disease, stroke, diabetes, and more. If you’re looking for a simple aid to shed unwanted pounds, we have an exciting peptide compound for you.
At Doctors Best Wellness Center, we pride ourselves on providing the utmost care for our patients and helping them look and feel the way they always imagined. We specialize in compounded semaglutide injections for weight loss support and look forward to serving you.
What is semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) produced in the gut. It can increase insulin production, a hormone that lowers the blood sugar level, while inhibiting glucagon secretion, which is a hormone that raises blood sugar. It can also reduce appetite and energy intake while delaying gastric emptying. Compounded semaglutide contains beneficial medications such as the amino acid L-carnitine, for example.
ARE SEMAGLUTIDE INJECTIONS RIGHT FOR YOU?
If any of the following situations apply, you may be a candidate for semaglutide injections to supplement proper diet and exercise.
- Are overweight or obese with a high BMI
- Have the desire to lose weight
- Want a lower glycemic index
- Have a weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol
THE BENEFITS OF SEMAGLUTIDE INJECTIONS
An easy, once-a-week injection of this peptide may yield several weight loss support benefits, such as:
THE RESULTS OF SEMAGLUTIDE INJECTIONS FOR WEIGHT LOSS
In 2022, The Jama Network published the results of a study conducted on weight loss outcomes associated with semaglutide treatment for patients that are overweight or obese. In this cohort study of 175 patients, the total body weight loss percentages achieved were 5.9% at three months and 10.9% at six months.
In 2021, The New England Journal of Medicine published the results of five phase-three trials involving the Semaglutide Treatment Effect in People (STEP). STEP was one of the largest clinical trial programs to date for obesity management. On average, participants on semaglutide lost nearly 15% of their body weight, while those in the placebo group lost an average of 2.4%.